The molecular basis of neurotrophic keratitis

Acta Ophthalmol Suppl (1985). 1989:192:115-34. doi: 10.1111/j.1755-3768.1989.tb07103.x.

Abstract

Endogenous proliferation of corneal epithelial cells is regulated by a bidirectional control process characterized by an adrenergic, cAMP-dependent 'off', and a cholinergic, muscarinic cGMP-dependent 'on' response. The adrenergic receptor(s) are located in the plasma membrane (microsomal fraction), whereas the novel feature of the system is a cholinergic receptor specific for acetylcholine (ACH) located in the nuclear membrane. Exogenous substances which raise intracellular cAMP levels such as isoproterenol or PGE1, shut off epithelial mitosis: and, carbamylcholine or ACH raise intranuclear cGMP levels and increase mitosis by specific, regulatory stimulation of RNA-polymerase II activity. We believe that this regulatory system explains the transitory mitotic suppression induced by superficial corneal wounding (interruption of adrenergic fibres, chalone-effect); and the marked, permanent depression of epithelial mitosis associated with decreased intracellular ACH levels which are produced by total corneal denervation, and which results in neurotrophic keratitis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2',3'-Cyclic-Nucleotide Phosphodiesterases / metabolism
  • Animals
  • Cells, Cultured
  • DNA-Directed DNA Polymerase / metabolism
  • DNA-Directed RNA Polymerases / metabolism
  • Endothelium, Corneal / cytology
  • Endothelium, Corneal / drug effects
  • Endothelium, Corneal / physiopathology*
  • Keratitis / etiology*
  • Keratitis / metabolism
  • Kinetics
  • Male
  • Mitosis / drug effects
  • Models, Molecular
  • Nucleotides, Cyclic / metabolism
  • Parasympathomimetics / pharmacology
  • Prostaglandins E / pharmacology
  • Protein Kinases / metabolism
  • Rabbits
  • Receptors, Adrenergic, beta / metabolism
  • Receptors, Cholinergic / metabolism
  • Signal Transduction
  • Sympathomimetics / pharmacology

Substances

  • Nucleotides, Cyclic
  • Parasympathomimetics
  • Prostaglandins E
  • Receptors, Adrenergic, beta
  • Receptors, Cholinergic
  • Sympathomimetics
  • Protein Kinases
  • DNA-Directed RNA Polymerases
  • DNA-Directed DNA Polymerase
  • 2',3'-Cyclic-Nucleotide Phosphodiesterases